Feature | April 30, 2007 | Cristen C. Bolan

Vital Signs 2.0 - Nuclear Medicine at the Bedside

The term “2.0” has become the catch phrase for all things next-gen. But is it just meaningless marketing jargon or new conventional wisdom? Or might it simply represent a logical stream of consciousness – making the obvious connections and then harnessing collective intelligence?
If you peruse Web developer O’Reilly Network’s site (www.oreillynet.com), it compares the transition from Web 1.0 to 2.0 to the paradigm leap that transitioned DoubleClick to Google AdSense, personal Web Sites to blogs and content management systems to wikis.
Similarly, medical imaging is poised to take its own rational leap by leveraging the powers of bioinformatics. When I asked SNM 2006-2007 President Martin P. Sandler, M.D., what he thought would be the most significant advancements in nuclear medicine over the next five years, his response bridged the perceived gap between biology and IT – the one which separates conferences like SNM and SIIM.
Dr. Sandler said that while there will be significant advances in translational imaging systems to speed up drug development and nanoparticle technology, he firmly stated, “I think quantification is the next big breakthrough in imaging technology.”
He referred to the use of quantitative analysis in clinical practice, providing medical specialists with hard facts to back visual findings and plan treatments. Dr. Sandler noted that, “in cardiac imaging, for example, these types of tools will allow us to quantify absolute bloodflow.” Which leads us to the next logical step – bringing nuclear medicine bedside.
By employing computational power, nuclear medicine will drive personalized medicine, looking at cell activities and developing specific imaging and therapeutic interventions tailored for individuals. “I think that the biggest advancement will be bringing quantitative measurements to the bedside,” said Dr. Sandler. Could this mean Nuclear Medicine 2.0?

Related Content

New ASNC SPECT Imaging Guideline Addresses Advances in Myocardial Perfusion Imaging
News | SPECT Imaging | June 21, 2018
The American Society of Nuclear Cardiology (ASNC) has published an update to its 2010 guidelines for single photon...
FDA Clears New Imaging Functionalities for Biograph mCT PET/CT Systems
Technology | PET-CT | June 21, 2018
Siemens Healthineers will announce U.S. Food and Drug Administration (FDA) clearance of four new system features for...
PET/CT Changes Care for 59 Percent of Suspected Recurrent Prostate Cancer Cases
News | Prostate Cancer | June 13, 2018
A recently presented investigational clinical trial evaluated the impact of 18F fluciclovine positron emission...
Nuclear imaging scan showing very good tissue delineation. Scan performed on a Biograph Vision positron emission tomography/computed tomography (PET-CT) system from Siemens Healthineers.

Nuclear imaging scan showing very good tissue delineation. It offers crisp overall image quality and sharply delineates the muscle and fat planes, vertebral margins and end plates, billiary radicals, renal calyces, aortic wall and papillary muscles of the heart. Scan performed on a Biograph Vision positron emission tomography/computed tomography (PET-CT) system from Siemens Healthineers.

Technology | PET-CT | June 05, 2018
June 5, 2018 — The U.S.
Emerging Trends in Nuclear Medicine
Feature | Nuclear Imaging | June 04, 2018 | By Jeff Zagoudis
Nuclear imaging and its various modalities have long played an important role in the diagnosis and treatment of numer
PET Imaging Agent Could Provide Early Diagnosis of Rheumatoid Arthritis

Coronal 18F-FEDAC PET/CT section of a mouse with collagen-induced arthritis. (A) On day 23 and day 37, increased uptake is noted in the front and hind paws of this mouse with collagen-induced arthritis. (B) Predictive performance of day 23 18F-FEDAC uptake for the development of clinical arthritis. ROC = receiver operating characteristic; Sn = sensitivity; Sp = specificity. Credit: Seoul National University and Ewha Womans University, Seoul, South Korea

News | PET Imaging | May 17, 2018
A novel positron emission tomography (PET) tracer developed by Korean researchers can visualize joint inflammation and...
PET Imaging Shows Protein Clumping May Contribute to Heart Failure Development
News | PET Imaging | May 11, 2018
A team led by Johns Hopkins University Researchers has discovered that protein clumps appear to accumulate in the...
News | Radiopharmaceuticals and Tracers | May 09, 2018
Blue Earth Diagnostics signed an exclusive, worldwide agreement with Scintomics GmbH, Germany, a specialist in...
Novel PET Agent Could Help Guide Therapy for Brain Diseases

Rat brain 11C‐Me‐NB1 PET images (0‐60 min) superimposed on an MRI template. Credit: SD Krämer et al., ETH Zurich, Zurich, Switzerland

News | PET Imaging | April 10, 2018
Researchers have developed a new imaging agent that could help guide and assess treatments for people with various...
Overlay Init